School of Medicine
Showing 11-20 of 27 Results
Adam de la Zerda
Associate Professor of Structural Biology and, by courtesy, of Electrical Engineering
Current Research and Scholarly Interests Molecular imaging technologies for studying cancer biology in vivo
Professor of Radiology (Canary Cancer Center)
Bio Dr. Demirci is currently a Professor with tenure at Stanford University School of Medicine and Principal Investigator of the Demirci Bio-Acoustic MEMS in Medicine (BAMM) Lab at the Canary Center at Stanford for Cancer Early Detection. He received his B.S. degree in Electrical Engineering in 1999 as a James B. Angell Scholar (summa cum laude) from University of Michigan, Ann Arbor. He received his M.S. degree in 2001 in Electrical Engineering, M.S. degree in Management Science and Engineering in 2005, and Ph.D. in Electrical Engineering in 2005, all from Stanford University.
BAMM Lab specializes in applying micro- and nanoscale technologies to problems in medicine and early cancer detection at the interface between micro/nanoscale engineering and medicine. Our goal is to apply innovative technologies to clinical problems. Our major research theme focuses on creating new microfluidic technology platforms targeting broad applications in medicine. In this interdisciplinary space at the convergence of engineering, biology and materials science, we create novel technologies for disposable point-of-care (POC) diagnostics and monitoring of infectious diseases, cancer and controlling cellular microenvironment in nanoliter droplets for biopreservation and microscale tissue engineering applications. These applications are unified around our expertise to test the limits of cell manipulation by establishing microfluidic platforms to provide solutions to real world problems at the clinic.
Our lab creates technologies to manipulate cells in nanoliter volumes to enable solutions for real world problems in medicine including applications in infectious disease diagnostics and monitoring for global health, cancer early detection, cell encapsulation in nanoliter droplets for cryobiology, and bottom-up tissue engineering. Dr. Demirci has published over 120 peer reviewed publications in journals including PNAS, Nature Communications, Advanced Materials, Small, Trends in Biotechnology, Chemical Society Reviews and Lab-chip, over 150 conference abstracts and proceedings, 10+ book chapters, and an edited book. His work was highlighted in Wired Magazine, Nature Photonics, Nature Medicine, MIT Technology Review, Reuters Health News, Science Daily, AIP News, BioTechniques, and Biophotonics. He is fellow-elect of the American Institute of Biological and Medical Engineering (AIMBE, 2017). His scientific work has been recognized by numerous national and international awards including the NSF Faculty Early Career Development (CAREER) Award (2012), the IEEE-EMBS Early Career Achievement Award (2012), Scientist of the year award from Stanford radiology Department (2017). He was selected as one of the world?s top 35 young innovators under the age of 35 (TR-35) by the MIT Technology Review at the age of 28. In 2004, he led a team that won the Stanford University Entrepreneur?s Challenge Competition and Global Start-up Competition in Singapore. His work has been translated to start-up companies including DxNow, KOEK Biotechnology and LEVITAS. There has been over 10,000 live births in the US, Europe, Asia, and Middle East using the sperm selection technology that came out of Dr. Demirci's lab.
Atman Desai, MD
Clinical Associate Professor, Neurosurgery
Current Research and Scholarly Interests Our laboratory aims to analyze and solve healthcare problems relating to neurosurgical care and spine care on a population level. Through the development of algorithms that can be applied to various large national and state-level healthcare datasets, our goal is to harness big data to:
1. Understand how quality in neurosurgical care and spine care can be defined in both short and long-term measures
2. Develop appropriate measures of quality neurosurgical and spine care
3. Create benchmarks for care in neurosurgery and spine surgery
4. Create multivariate bio-statistical models of pre-operative, peri-operative and post-operative events and long term patient outcomes
5. Understand how existing paradigms in neurosurgical care and spine care can be potentially improved to improve patient outcomes
In addition to our population level research, our laboratory has been a national pioneer in integrating prospective outcomes driven medical informative and database systems into the electronic health record. This allows us to identify pre- and post-operative treatment measures that influence patient outcomes, and in doing so improve patient safety and maximize the efficacy of current treatments for neurosurgical and spine patients.
Clinical Assistant Professor, Medicine - Endocrinology, Gerontology, & Metabolism
Bio Dr. Kaniksha Desai is a board-certified endocrinologist and clinical assistant professor of endocrinology at Stanford University. She completed her endocrinology fellowship at the Mayo Clinic, with an emphasis on the management of patients with thyroid cancer. Dr. Desai?s clinical practice focuses on the management of patients with thyroid diseases, including thyroid nodules and thyroid cancers, and the management of patients with pituitary disorders. She also maintains board certification in neck ultrasonography and internal medicine.
Professor (Research) of Medicine (Biomedical Informatics), of Biomedical Data Science and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly Interests Dr. Desai is the Director of the Quantitative Sciences Unit. She is interested in the application of biostatistical methods to all areas of medicine including oncology, nephrology, and endocrinology. She works on methods for the analysis of epidemiologic studies, clinical trials, and studies with missing observations.
Associate Professor of Medicine (Pulmonary and Critical Care)
Current Research and Scholarly Interests We investigate the cellular and molecular events that regulate proper development of the lungs, including how the gas exchange region is maintained and renewed throughout life. We apply this knowledge to dissect how dysregulation of these normal processes can cause or contribute to specific lung diseases like pulmonary fibrosis, emphysema, and lung cancer, and we are interested in uncovering how lung stem cells are regulated in the hopes of harnessing them as a regenerative therapy for patients.
Professor of Radiology (Abdominal Imaging) at the Stanford University Medical Center
Current Research and Scholarly Interests Imaging of gastrointestinal tract cancer
Simulated learning environment
Instructor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly Interests The overall goal of my research is to understand the molecular pathogenesis of liver cancer and identify biologically relevant prognostic biomarkers and molecular targets for therapy in patients with hepatocellular carcinoma (HCC). My long-term objective is to improve the clinical outcome of patients with liver cancer.
Maximilian Diehn, MD, PhD
Associate Professor of Radiation Oncology (Radiation Therapy)
Current Research and Scholarly Interests My laboratory focuses on two main areas: 1) cancer stem cell biology and 2) novel biomarkers for identifying the presence of malignant cells (diagnostic), predicting outcome (prognostic), and predicting response to therapy (predictive). Areas of study include cancers of the lung, breast, and gastrointestinal system. Clinically I specialize in the treatment of lung cancer and applications of stereotactic ablative radiotherapy and perform both prospective and retrospective clinical studies.
Specialist, Community Outreach & Communications, Stanford Cancer Institute
Current Role at Stanford Specialist, Community Outreach and Communications